The impact of a multi-domain intervention on cerebral glucose metabolism: analysis from the randomized ancillary FDG PET MAPT trial.
Julien DelrieuThierry VoisinLaure Saint-AubertIsabelle CarrieChristelle CantetBruno VellasPierre PayouxSandrine AndrieuPublished in: Alzheimer's research & therapy (2020)
ClinicalTrials.gov Identifier, NCT01513252 .